Top Clinical Trials companies in China by Free Cash Flow

This ranking features the top 24 Clinical Trials companies in China ranked by Free Cash Flow, totalling a Free Cash Flow of USD -852.55 M, for January 15, 2025.

China

Clinical Trials

#	Name	Free Cash Flow	Reported Date	Stock Price	Change	Country
1	Akeso, Inc. 1 9926.HK	USD 223.71 M	Dec. 31, 2023	USD 7.28	2.32%	China
2	Hua Medicine (Shanghai) Ltd. 2 2552.HK	USD 123.88 M	Dec. 31, 2023	USD 0.17	-0.02%	China
3	Hangzhou Tigermed Consulting Co., Ltd. 3 3347.HK	USD 117.85 M	Dec. 31, 2023	USD 3.72	2.09%	China
4	Joinn Laboratories(China)Co.,Ltd. 4 6127.HK	USD 60.59 M	Dec. 31, 2023	USD 1.06	2.98%	China
5	Mega Genomics Limited 5 6667.HK	USD 17.97 M	Dec. 31, 2023	USD 1.18	-0.89%	China
6	Shanghai Henlius Biotech, Inc. 6 2696.HK	USD 5.14 M	Dec. 31, 2023	USD 2.59	-10.24%	China
7	TOT BIOPHARM International Company Limited 7 1875.HK	USD -20.67 M	Dec. 31, 2023	USD 0.24	4.98%	China
8	HBM Holdings Limited 8 2142.HK	USD -21.60 M	Dec. 31, 2023	USD 0.34	-0.77%	China
9	Kindstar Globalgene Technology, Inc. 9 9960.HK	USD -26.71 M	Dec. 31, 2023	USD 0.15	-0.02%	China
10	Adagene Inc. 10 ADAG	USD -28.54 M	Dec. 31, 2023	USD 1.80	1.12%	China
11	Alphamab Oncology 11 9966.HK	USD -33.67 M	Dec. 31, 2023	USD 0.43	4.62%	China
12	Staidson (Beijing) BioPharmaceuticals Co., Ltd. 12 300204.SZ	USD -36.69 M	Dec. 31, 2023	USD 0.95	3.28%	China
13	Burning Rock Biotech Limited 13 BNR	USD -37.35 M	Dec. 31, 2023	USD 6.55	-6.69%	China
14	Lepu Biopharma Co., Ltd. 14 2157.HK	USD -41.13 M	Dec. 31, 2023	USD 0.31	4.82%	China
15	Connect Biopharma Holdings Limited 15 CNTB	USD -48.22 M	Dec. 31, 2023	USD 1.06	-2.75%	China
16	ImmuneOnco Biopharmaceuticals (Shanghai) Inc. 16 1541.HK	USD -52.15 M	Dec. 31, 2023	USD 0.62	4.32%	China
17	Jacobio Pharmaceuticals Group Co., Ltd. 17 1167.HK	USD -56.74 M	Dec. 31, 2023	USD 0.17	1.52%	China
18	JW (Cayman) Therapeutics Co. Ltd 18 2126.HK	USD -58.17 M	Dec. 31, 2023	USD 0.17	2.32%	China
19	Abbisko Cayman Limited 19 2256.HK	USD -64.37 M	Dec. 31, 2023	USD 0.57	1.58%	China
20	Keymed Biosciences Inc. 20 2162.HK	USD -96.66 M	Dec. 31, 2023	USD 3.69	1.93%	China
21	Ascentage Pharma Group International 21 6855.HK	USD -110.27 M	Dec. 31, 2023	USD 5.19	2.25%	China
22	InnoCare Pharma Limited 22 9969.HK	USD -130.43 M	Dec. 31, 2023	USD 0.69	3.45%	China
23	Zai Lab Limited 23 9688.HK	USD -206.67 M	Dec. 31, 2023	USD 2.49	0.18%	China
24	RemeGen Co., Ltd. 24 9995.HK	USD -331.64 M	Dec. 31, 2023	USD 1.59	2.46%	China

Frequently Asked Questions

Which Clinical Trials company in China has the highest Free Cash Flow ?

The Clinical Trials company in China with the highest Free Cash Flow is Akeso, Inc. (HKSE: 9926.HK) at USD 223.71 M.
Which Clinical Trials company in China has the lowest Free Cash Flow ?

The Clinical Trials company in China with the lowest Free Cash Flow is RemeGen Co., Ltd. (HKSE: 9995.HK) at USD -331.64 M.

What are the top 10 Clinical Trials companies in China by Free Cash Flow ?

The top 10 Clinical Trials companies in China by Free Cash Flow are Akeso, Inc., Hua Medicine (Shanghai) Ltd., Hangzhou Tigermed Consulting Co., Ltd., Joinn Laboratories(China)Co.,Ltd., Mega Genomics Limited, Shanghai Henlius Biotech, Inc., TOT BIOPHARM International Company Limited, HBM Holdings Limited, Kindstar Globalgene Technology, Inc. and Adagene Inc..
What are the bottom 10 Clinical Trials companies in China by Free Cash Flow ?

The bottom 10 Clinical Trials companies in China by Free Cash Flow are RemeGen Co., Ltd., Zai Lab Limited, InnoCare Pharma Limited, Ascentage Pharma Group International, Keymed Biosciences Inc., Abbisko Cayman Limited, JW (Cayman) Therapeutics Co. Ltd, Jacobio Pharmaceuticals Group Co., Ltd., ImmuneOnco Biopharmaceuticals (Shanghai) Inc. and Connect Biopharma Holdings Limited.